Nutex Health is rated Buy, with a DCF-based price target of $199.31, offering 19.8% upside from $166.40. NUTX's revenue ...

Transformative Fiscal 2026 Focused on Addressing Legacy Issues While Strengthening Foundation of the Company Beneficient Clears Litigation Hurdles as it Positions to Capitalize on New Opportunities fo ...

Total revenues decreased by 14.0% year over year to RMB227.7 million (US$33.0 million)[1].Income from operations was RMB28.7 million (US$4.2 million) [1]  compared to RMB11.3 million for the first ...

Vault Ventures Plc - Annual Report for the Year Ended 31 December 2025 PR Newswire LONDON, United Kingdom, June 30 30 June 2026 Vault ...